TECHNOLOGYSCMP CHINA
The next tech war? Why biotech may become a new US-China battleground
The US-China geopolitical rivalry may expand into biotechnology, with American pharmaceutical firms relying on China's growing industry for drug candidates. China's biotech sector, previously seen as a low-cost manufacturing hub, has gained momentum through sustained investment and faster development.
Mentioned
Related Signal
Adjacent reporting
- China's biotech boom alarms Western lawmakers, investors
- Opinion: STAT+: Pharma and biotech leaders are destroying their own industry
- Growing US reliance on Chinese biotechs prompts national security fears
- STAT+: The China question is tearing biotech apart
- Ukraine's fast-growing defense tech sector takes center stage in Iran war
- STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much more